[ Intravenous treatment of postpartum anemia with <font color="red">trivalent_2</font> <font color="red">ferrum_2</font> <font color="red">preparation_2</font> <font color="red">]_2</font> . 
<br>
<br> AIM OF THE STUDY To assess the effectivity and safeness of intravenous treatment of pospartal anemia with <font color="red">trivalent_2</font> <font color="red">ferrum_2</font> <font color="red">preparation_2</font> <font color="red">._2</font> 
<br> TYPE OF THE STUDY Prospective randomized study . 
<br> SETTING Department of Obstetric and Gynecology 2nd Medical Faculty Charles University and Teaching Hospital Motol , Prague , and Department of Obstetric and Gynecology 1st Medical Faculty and Teaching Hospital Bulovka , Prague . 
<br> METHODS 500 mg of <font color="red">sacharose_2</font> <font color="red">ferric_2</font> <font color="red">oxide_2</font> <font color="red">(_2</font> <font color="red">Venofer_2</font> <font color="red">)_2</font> was intravenously administered in two days regimen to 50 women with clinical and lab signs of postpartal anemia . The effect of administered drug was determined by comparsion of values of red blood count recovered before the treatment , 2nd or 3rd day post administration and two weeks later . The serum values of soluble transferrin receptors and ferritin were observed as markers of iron cell saturation and body iron reserves , too . Integral part of the study was the monitoring of adverse events during the treatment . 
<br> RESULTS <font color="red">Venofer_2</font> came in sight as effective drug in the treatment of pospartal anemia and could become as the alternative to blood transfusion in mid - severe cases . It should be emphasized that we have not encountered any serious adverse event with <font color="red">intravenous_1</font> <font color="red">trivalent_2</font> <font color="red">saccharose_2</font> <font color="red">ferric_2</font> <font color="red">oxide_2</font> <font color="red">treatment_1</font> <font color="red">._1</font>